Data | Ora | Fonte | Titolo | Simbolo | Compagnia |
16/08/2022 | 18:46 | GlobeNewswire Inc. | Reunion Neuroscience Inc. to Commence Trading on the Toronto Stock Exchange on August 17, 2022 | NASDAQ:FTRP | Field Trip Health Ltd |
15/08/2022 | 23:09 | GlobeNewswire Inc. | Reunion Neuroscience Inc. (Formerly Field Trip Health Ltd.) Reports Fiscal First Quarter 2023 Financial Results, Completed Corporate Reorganization on August 11, 2022 | NASDAQ:FTRP | Field Trip Health Ltd |
11/08/2022 | 22:28 | GlobeNewswire Inc. | Field Trip Announces Closing of Plan of Arrangement and $19.9 Million Private Placement Financing | NASDAQ:FTRP | Field Trip Health Ltd |
08/08/2022 | 14:00 | GlobeNewswire Inc. | Field Trip Health Ltd. Schedules Fiscal First Quarter 2023 Conference Call for Tuesday, August 16, 2022, at 8:30 AM ET | NASDAQ:FTRP | Field Trip Health Ltd |
05/08/2022 | 00:29 | GlobeNewswire Inc. | Field Trip Health Ltd. Receives Conditional Approval for Listing of Common Shares of Field Trip Health & Wellness Ltd. on the TSX Venture Exchange | NASDAQ:FTRP | Field Trip Health Ltd |
21/07/2022 | 13:30 | GlobeNewswire Inc. | Field Trip Announces First Dosings in Phase I Clinical Study of FT-104 | NASDAQ:FTRP | Field Trip Health Ltd |
06/07/2022 | 14:25 | TipRanks | Analysts Offer Insights on Healthcare Companies: Ayala Pharmaceuticals (AYLA) and Field Trip Health (FTRP) | NASDAQ:FTRP | Field Trip Health Ltd |
30/06/2022 | 04:00 | GlobeNewswire Inc. | Field Trip Health Ltd. Reports Fiscal Fourth Quarter and Full Year 2022 Financial Results and Provides Business Update Including Corporate Reorganization | NASDAQ:FTRP | Field Trip Health Ltd |
29/06/2022 | 22:37 | GlobeNewswire Inc. | Field Trip Health Ltd. Receives Final Court Approval for Reorganization of the Discovery and Wellness Businesses Into Two Publicly Traded Companies | NASDAQ:FTRP | Field Trip Health Ltd |
28/06/2022 | 02:21 | GlobeNewswire Inc. | Field Trip Health Ltd. Announces Voting Results From Special Shareholder Meeting | NASDAQ:FTRP | Field Trip Health Ltd |
23/06/2022 | 13:41 | GlobeNewswire Inc. | Field Trip Health Ltd. to Present at the H.C. Wainwright 1st Annual Mental Healthcare Conference on June 27, 2022 | NASDAQ:FTRP | Field Trip Health Ltd |
22/06/2022 | 20:41 | GlobeNewswire Inc. | Field Trip Health Ltd. Schedules Fiscal Fourth Quarter and Full Year 2022 Results Conference Call for Thursday, June 30, 2022 at 8:30 AM ET | NASDAQ:FTRP | Field Trip Health Ltd |
15/06/2022 | 00:03 | GlobeNewswire Inc. | Field Trip Health Ltd. Announces Increased Participation in Arrangement Financing and Postponement of Shareholder Meeting Date | NASDAQ:FTRP | Field Trip Health Ltd |
12/05/2022 | 13:30 | GlobeNewswire Inc. | Field Trip and Nue Life Are Collaborating To Bring Psychedelic Therapy Into the Home | NASDAQ:FTRP | Field Trip Health Ltd |
29/04/2022 | 14:35 | GlobeNewswire Inc. | KCSA Psychedelics Virtual Investor Conference Presentations Now Available for On-Demand Viewing | NASDAQ:FTRP | Field Trip Health Ltd |
29/04/2022 | 14:12 | GlobeNewswire Inc. | Field Trip Health Ltd. to Participate in Upcoming Investor Conferences in May 2022 | NASDAQ:FTRP | Field Trip Health Ltd |
29/04/2022 | 00:19 | GlobeNewswire Inc. | Field Trip Health Ltd. Announces Intention to Separate the Field Trip Discovery and Field Trip Health Divisions Into Two Independent Public Companies | NASDAQ:FTRP | Field Trip Health Ltd |
25/04/2022 | 14:35 | GlobeNewswire Inc. | KCSA Psychedelics Virtual Investor Conference Agenda Announced for April 27th & 28th | NASDAQ:FTRP | Field Trip Health Ltd |
18/04/2022 | 15:00 | GlobeNewswire Inc. | Field Trip Health Ltd. to Participate in Upcoming Investor Conferences | NASDAQ:FTRP | Field Trip Health Ltd |
05/04/2022 | 13:51 | GlobeNewswire Inc. | Field Trip Health Ltd. Granted US Patent Covering Novel Psychedelic Molecule FT-104 | NASDAQ:FTRP | Field Trip Health Ltd |
23/03/2022 | 13:00 | GlobeNewswire Inc. | Field Trip Health Ltd. to Participate in Maxim Group 2nd Annual Virtual Growth Conference | NASDAQ:FTRP | Field Trip Health Ltd |
09/03/2022 | 14:00 | GlobeNewswire Inc. | Field Trip Health Ltd. to Participate in 34th Annual Roth Conference in March 2022 | NASDAQ:FTRP | Field Trip Health Ltd |
03/03/2022 | 13:45 | PR Newswire (US) | Field Trip Health and Cerebral Partner to Provide End-to-End Mental Health Care | NASDAQ:FTRP | Field Trip Health Ltd |
15/02/2022 | 23:15 | GlobeNewswire Inc. | Field Trip Health Ltd. Reports Third Fiscal Quarter 2022 Financial Results and Provides Business Update | NASDAQ:FTRP | Field Trip Health Ltd |
01/02/2022 | 14:00 | GlobeNewswire Inc. | Field Trip Health Ltd. Schedules Third Fiscal Quarter 2022 Financial Results Conference Call for February 16, 2022 at 8:30 AM ET | NASDAQ:FTRP | Field Trip Health Ltd |
18/01/2022 | 14:00 | GlobeNewswire Inc. | Field Trip Health Ltd. to Participate in Citi’s Psychedelic Drug Video Call Series | NASDAQ:FTRP | Field Trip Health Ltd |
11/01/2022 | 16:00 | GlobeNewswire Inc. | Field Trip Receives Notice of Allowance for US Patent Application Covering FT-104 (Isoprocin Glutarate), its Novel Psychedelic Molecule in Development | NASDAQ:FTRP | Field Trip Health Ltd |
06/01/2022 | 14:00 | GlobeNewswire Inc. | Field Trip Announces Intention to Make Applications on Behalf of Patients to Health Canada’s Special Access Program (SAP) for Access to Psilocybin and MDMA-Assisted Therapies | NASDAQ:FTRP | Field Trip Health Ltd |
05/01/2022 | 13:30 | GlobeNewswire Inc. | Field Trip Health Ltd. to Participate in H.C. Wainwright Bioconnect Virtual Conference in January 2022 | NASDAQ:FTRP | Field Trip Health Ltd |
14/12/2021 | 13:30 | GlobeNewswire Inc. | Field Trip Launches Site Management Organization (SMO) Services, Hires Stéphan Côté as Head of Quality | NASDAQ:FTRP | Field Trip Health Ltd |